U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748572) titled 'PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France' on June 02, 2025.
Brief Summary: To evaluate safety and performance of the phenox GmbH Flow Diverter p64, p64 MW, and p48MW in France, this registry will include subjects with intracranial aneurysms (anterior and posterior) who are treated with a phenox GmbH Flow Diverter. The subjects will be treated according to the standard of care in the participating sites.
Study Start Date: March 07, 2025
Study Type: OBSERVATIONAL
Condition:
Intracranial Aneurysms
Intervention:
DEVICE: Aneurysm treatment with a Flow Modulation Device
Treatment of an...